Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics.
Novel, synthetic cannabimimetics and delta 9-tetrahydrocannabinol were found to enhance the binding of [3H]flunitrazepam to mouse brain in vivo. This property, suggestive of facilitation of binding to benzodiazepine receptors, is consistent with the potentiation of the anticonvulsant activity of diazepam against pentylenetetrazol by these compounds. The relative potencies of delta 9-tetrahydrocannabinol and the new cannabimimetics for enhancing [3H]flunitrazepam binding in vivo could also be correlated with their relative analgesic efficacies. Similar pharmacological stereospecificity was displayed for both binding enhancement and analgesic effects. The following order of decreasing potency was observed: N-methyllevonantradol and (-)-CP-55,244 greater than levonantradol, canbisol, CP-42,096 and (-)-CP-55,940 greater than 9-beta-normethyl-9-beta-hydroxyhexahydrocannabinol, nabilone and CP-47,497 greater than delta 9-tetrahydrocannabinol. Dextronantradol, (+)-CP-55,940 and (+)-CP-55,244 were considerably less active than the respective (-)-enantiomers; cannabidiol was inactive. Extensive investigation of structure versus activity led to N-methyllevonantradol and the 3-(2-hydroxyphenyl)cyclohexanols derivative, (-)-CP-55,244, which are approximately 1000-fold more potent than delta 9-tetrahydrocannabinol.
Koe
B K
BK
Milne
G M
GM
Weissman
A
A
Johnson
M R
MR
Melvin
L S
LS
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D002186:Cannabinoids / Q000494:pharmacology*; D002531:Cerebellum / Q000032:analysis; D006152:Cyclic GMP / Q000032:analysis; D003975:Diazepam / Q000494:pharmacology; D013759:Dronabinol / Q000494:pharmacology*; D005445:Flunitrazepam / Q000378:metabolism*; D008297:Male; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D011963:Receptors, GABA-A / Q000187:drug effects; D014316:Tritium
D000700:Analgesics; D000927:Anticonvulsants; D002186:Cannabinoids; D011963:Receptors, GABA-A; D014316:Tritium; D005445:Flunitrazepam; D013759:Dronabinol; D006152:Cyclic GMP; D003975:Diazepam; D002118:Calcium